ITOS - Iteos Therapeutics  - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ITOS is currently covered by 3 analysts with an average price target of $31.75. This is a potential upside of $24.32 (327.32%) from yesterday's end of day stock price of $7.43.

Iteos Therapeutics 's activity chart (see below) currently has 12 price targets and 18 ratings on display. The stock rating distribution of ITOS is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 7.78% with an average time for these price targets to be met of 172 days.

Highest price target for ITOS is $21, Lowest price target is $21, average price target is $31.75.

Most recent stock forecast was given by SWAYAMPAKULA RAMAKANTH from HC WAINWRIGHT on 13-Dec-2024. First documented stock forecast 18-Aug-2020.

Best performing analysts who are covering ITOS - Iteos Therapeutics :

David Nierengarten Daina Graybosch Swayampakula Ramakanth Christopher Neyor

Currently out of the existing stock ratings of ITOS, 11 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$21

$13.58 (183.02%)

$46

12 days ago
(13-Dec-2024)

1/9 (11.11%)

$13.35 (174.51%)

198

Buy

$29

$21.58 (290.84%)

$32

1 years 1 months 12 days ago
(13-Nov-2023)

0/2 (0%)

$19.4 (202.08%)

Buy

$33

$25.58 (344.74%)

$33

1 years 2 months 7 days ago
(18-Oct-2023)

1/5 (20%)

$24.11 (271.20%)

490

Buy

$59

$51.58 (695.15%)

$54

2 years 7 months 12 days ago
(13-May-2022)

0/2 (0%)

$40.42 (217.55%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ITOS (Iteos Therapeutics ) average time for price targets to be met?

On average it took 172 days on average for the stock forecasts to be realized with a an average price target met ratio 7.78

Which analyst has the current highest performing score on ITOS (Iteos Therapeutics ) with a proven track record?

DAVID NIERENGARTEN

Which analyst has the current lower performing score on ITOS (Iteos Therapeutics ) with a proven track record?

CHRISTOPHER NEYOR

Which analyst has the most public recommendations on ITOS (Iteos Therapeutics )?

David Nierengarten works at WEDBUSH and has 7 price targets and 4 ratings on ITOS

Which analyst is the currently most bullish on ITOS (Iteos Therapeutics )?

Daina Graybosch with highest potential upside - $51.58

Which analyst is the currently most reserved on ITOS (Iteos Therapeutics )?

Swayampakula Ramakanth with lowest potential downside - $13.58

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?